期刊文献+

受体活性修饰蛋白病理生理作用的研究进展

Research progress of the pathophysiological role of receptor activity modifying proteins
原文传递
导出
摘要 受体活性修饰蛋白(RAMPs)是一种具有单一跨膜功能域的蛋白,它可以与降钙素基因相关肽家族(CGRP)受体、降钙素受体(CTR)及降钙素受体样受体(CRLR)等Ⅱ型G蛋白偶联受体(GPCRs)相互作用,形成稳定的异二聚体在细胞膜上表达。不同的RAMPs可与降钙素受体样受体(CRLR)或降钙素受体(CTR)结合,形成对配体具有特异性亲和的不同受体表型,从而决定受体的生物学效应。此外,RAMPs还能与其他GPCRs相互作用,表明RAMPs在G蛋白偶联受体功能调节中具有更为广泛的作用。RAMPs对GPCRs的调节依赖于它的分子基础。RAMPs的研究为GPCRs受体功能及CGRP信号转导的研究提供了新思路。 Receptor activity modifying proteins (RAMPs) is a kind protein with transmembrane function- ality. RAMPs can interact with TypeII G protein coupled receptors (GPCRs) such as calcitonin gene-related peptide receptor (CGRPR), calcitonin receptor (CTR) and calcitonin receptor-like receptor (CRLR), to form a stable het- erodimer expression on the cell membrane. Different RAMPs can combine with CRLR or CTR to produce different receptor phenotypes with ligand-specific affinity and thus can decide biological effect of the receptors. In addition, RAMPs can also interact with other GPCRs, which promise broader application in function regulation of G-protein- coupled receptor of RAMPs'. RAMPs' regulation of GPCRs depends on its molecular basis. Our studies of RAMPs provides a new perspective to further researches on GPCRs functionality and CGRP signal transduction.
出处 《国际生物医学工程杂志》 CAS 2013年第1期51-55,共5页 International Journal of Biomedical Engineering
关键词 受体活性修饰蛋白 降钙素基因相关肽 降钙素受体 降钙素受体样受体 G蛋白 偶联受体 Receptor activity modifying proteins Calcitonin gene-related peptide Calcitonin receptor Calcitonin receptor-like receptor G protein coupled receptors
  • 相关文献

参考文献36

  • 1Choe HW, Park JH, Kim YJ, et al. Transmembrane signaling by GPCRs: insight from rhodopsin and opsin structures[J]. Neurophar?macology, 2011, 60(1): 52-57.
  • 2Cottrell GS, Alemi F, Kirkland JG, et al. Localization of calcitonin receptor-like receptor (CLR) and receptor activity-modifying protein I (RAMPI) in human gastrointestinal tract[J]. Peptides, 2012, 35(2): 202-211.
  • 3McLatchie LM, Fraser NJ, Main MJ, et al. RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor[J]. Nature, 1998, 393(6683): 333-339.
  • 4Fitzsimmons TJ, Zhao Xi-lin, Wank SA. The extracellular domain of receptor activity-modifying protein 1 is sufficient for calcitonin receptor-like receptor function[J]. J Bioi Chern, 2003, 278 (16): 14313-14320.
  • 5Granholm S, Henning P, Lerner UH. Comparisons between the effects of calcitonin receptor-stimulating peptide and intermedin and other peptides in the calcitonin family on bone resorption and osteoclastogenesis[J]. J Cell Biochem, 2011, 112(11): 3300-3312.
  • 6Kamiyoshi A, Sakurai T, Ichikawa-Shindo Y, et al, Endogenous alpha-calcitonin gene-related peptide mitigates liver fibrosis in chronic hepatitis induced by repeated administration of concanavalin A[J]. Liver Int, 2009, 29(5): 642-649.
  • 7Drake WM, Lowe SR, Mirtella A, et al. Desensitisation of calcitonin gene-related peptide responsiveness but not adrenomedullin responsiveness in vascular smooth muscle cells[J]. J Endocrinol, 2000, 165(1): 133-138.
  • 8Bell D, Campbell M, Ferguson M, et al. AM(I)-receptor-dependent protection by intermedin of human vascular and cardiac non?vascular cells from ischaemia-reperfusion injury[J]. J Physiol, 2012, 590(Pt 5):]]81-]]97.
  • 9Ichikawa-Shindo Y, Sakurai T, Kamiyoshi A, et al. The GPCR modulator protein RAMP2 is essential for angiogenesis and vascular integrity[J]. J Clin Invest, 2008, 118(1): 29-39.
  • 10Hay DL, Poyner DR, Sexton PM. GPCR modulation by RAMPs[J]. Pharmacol Ther, 2006,109(1-2): 173-197.

二级参考文献20

  • 1陆琰,张洹.干细胞向胰岛样细胞诱导分化的研究进展[J].生命科学,2006,18(1):75-79. 被引量:2
  • 2孙吉平,杨于嘉,王晓莉,宋建辉,贾延劼.胰腺十二指肠同源框-1基因促进大鼠骨髓间充质干细胞分化为胰岛样细胞[J].中国科学(C辑),2006,36(2):171-179. 被引量:4
  • 3Shapiro AM, Lakey JR, Ryan EA, et al. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen[J]. N Engl J Med, 2000, 343(4): 230- 238.
  • 4Friedenstein AJ, Gorskaja JF, Kulagina NN. Fibroblast precursors in normal and irradiated mouse hematopoietic organs[J]. Exp Hematol, 1976, 4(5): 267-274.
  • 5Caplan AI. Mesenchymal stem cells[J]. J Orthop Res, 1991, 9(5): 641-650.
  • 6Rice CM, Clavel C, Mazo M, et al. Multipotent adult progenitor cell isolation and proliferation in cytokine and serum-free medium conditioned by rat B104 cells[J]. Br J Haematol, 2010, 148(3): 441- 444.
  • 7Delcroix GJ, Curtis KM, Schiller PC, et al. EGF and bFGF pre- treatment enhances neural specification and the response to neuronal commitment of MIAMI cells[J]. Differentiation, 2010, 80(4- 5): 213-227.
  • 8Zuba-Surma EK, Kucia M, Abdel-Latif A, et al. Morphological characterization of very small embryonic-like stem cells (VSELs) by ImageStream system analysis[J]. J Cell Mol Med, 2008, 12(1): 292- 303.
  • 9Vija L, Farge D, Gautier JF, et al. Mesenchymal stem cells: Stem cell therapy perspectives for type 1 diabetes[J]. Diabetes Metab, 2009, 35(2): 85-93.
  • 10Tang Dong-qi, Cao Li-zhen, Burkhardt BR, et al. In vivo and in vitro characterization of insulin-producing cells obtained from murine bone marrow[J]. Diabetes, 2004, 53(7): 1721-1732.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部